← Eichor
Study identifier: NCT07218445 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Condition: Obesity · Menopause Hot Flashes  ·  Sponsor: Mayo Clinic

PhasePhase 4
Planned participants40
Who can joinFemale, 46 Years to 60 Years
Healthy volunteersYes

About this study

The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.

This description comes directly from the study's public registry record.

Talk to the study team

Tina Taaffe  ·  904-953-4769  ·  taaffe.christina@mayo.edu

Lauren Uy  ·  904-953-5337  ·  uy.lauren@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo Clinic in FloridaJacksonville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07218445